Manuela Iezzi

University of Chieti-Pescara — Italy

Medicine · Health Sciences

47h-index7.0kcitations383works0.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(96), Immunotherapy and Immune Responses(90), HER2/EGFR in Cancer Research(53), CAR-T cell therapy research(44), Immune cells in cancer(32)

Publications382 total

Liver‐specific <scp>BAG3</scp> knockout delays chemically induced hepatocellular carcinoma development
FEBS Journal·2026
Systematic Phenotyping and Molecular Analysis of the Woozy Mouse: A Preclinical Model of Cerebellar Ataxia
Molecular Neurobiology·2025Open Access
Supplementary Online Material from 3D-Informed Targeting of the Trop-2 Signal-Activation Site Drives Selective Cancer Vulnerability
2025Open Access
Movie S1 from 3D-Informed Targeting of the Trop-2 Signal-Activation Site Drives Selective Cancer Vulnerability
2025Open Access
IL-7 promotes the formation of DNA double strand breaks and DNA repair in murine pro-B cells
Frontiers in Immunology·2025Open Access
Abstract 5846: A potent STING agonist induces endothelial PD-L1 and enhances antitumor efficacy of a novel PD-L1/PD-L2 antibody
Cancer Research·2025
Abstract 1278: Tertiary lymphoid structure formation in patient-derived xenograft (PDX) of head and neck paraganglioma: A novel xenogeneic model
Cancer Research·2025
Abstract 7304: Cytotoxic PD-L1/PD-L2 dual-specific antibodies couple tumor stroma remodeling with checkpoint blockade to drive rejection of “cold” cancers
Cancer Research·2025
LGALS3BP antibody-drug conjugate enhances tumor-infiltrating lymphocytes and synergizes with immunotherapy to restrain neuroblastoma growth
Journal of Translational Medicine·2025· 6 citedOpen Access
OC.11.1 THE POTENTIAL ROLE OF CIRCULATING CYTOKINES AND CHEMOKINES TO PREDICT INTESTINAL FAILURE IN PATIENTS AFFECTED BY SHORT BOWEL SYNDROME
Digestive and Liver Disease·2025
17(<i>R</i>)-Resolvin D1 protects against sickle cell–related inflammatory cardiomyopathy in humanized mice
Blood·2025· 5 citedOpen Access
Enhancing PDAC therapy: Decitabine-olaparib synergy targets KRAS-dependent tumors
iScience·2025Open Access
P0122 The Potential Role of Circulating Cytokines and Chemokines To Predict Intestinal Failure in Patients Affected by Short Bowel Syndrome
Journal of Crohn s and Colitis·2025
Paving the way for personalized therapies in PDAC: enhanced antitumor activity of decitabine and PARPi treatment in PDAC with a transcriptomic-based KRAS dependency
Pancreatology·2024
Discrimination of Different Human Cell Lines by Using FT-IR Spectra Spectroscopy
2024· 1 citedOpen Access
Movie S1 from 3D-informed targeting of the Trop-2 signal-activation site drives selective cancer vulnerability
2024Open Access
Movie S1 from 3D-informed targeting of the Trop-2 signal-activation site drives selective cancer vulnerability
2024Open Access
Supplementary Online Material from 3D-informed targeting of the Trop-2 signal-activation site drives selective cancer vulnerability
2024Open Access
Supplementary Online Material from 3D-informed targeting of the Trop-2 signal-activation site drives selective cancer vulnerability
2024Open Access
Data from 3D-informed targeting of the Trop-2 signal-activation site drives selective cancer vulnerability
2024Open Access
page 1 of 20Next →

Frequent Co-authors

Piero Musiani(19), Guido Forni(13), Pier‐Luigi Lollini(12), Federica Cavallo(11), Alessia Lamolinara(11), Augusto Amici(9), Carla De Giovanni(9), Vincenzo Bronte(7), Claudia Curcio(7), Emma Di Carlo(7), Patrizia Nanni(7), Elena Quaglino(6), Stefano Iacobelli(6), Giordano Nicoletti(6), Stefania Croci(6), Lorena Landuzzi(6), Stefano Ugel(5), Francesco De Sanctis(5), Cosmo Rossi(5), Mauro Piantelli(5)